Oxford Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Oxford Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,259	Closed	-$1.38M	–	753
2019 Q4	$1.38M	Sell	9,259 -10,236	-53%	-$1.39M	0.04%	644
2019 Q3	$2.5M	Buy	+19,495	New	+$2.61M	0.06%	421
2019 Q2	–	Sell	-16,972	Closed	-$2.43M	–	1840
2019 Q1	$2.43M	Sell	16,972 -8,734	-34%	-$1.14M	0.05%	485
2018 Q4	$3.19M	Buy	+25,706	New	+$3.81M	0.08%	275
2018 Q3	–	Sell	-13,129	Closed	-$2.27M	–	1812
2018 Q2	$2.27M	Buy	13,129 +64	+0.5%	+$10.5K	0.04%	596
2018 Q1	$1.97M	Buy	13,065 +2,382	+22%	+$349K	0.04%	591
2017 Q4	$1.46M	Buy	+10,683	New	+$1.48M	0.03%	741
2017 Q2	–	Sell	-31,673	Closed	-$4.6M	–	1584
2017 Q1	$4.6M	Sell	31,673 -7,574	-19%	-$986K	0.11%	168
2016 Q4	$4.28M	Buy	39,247 +1,889	+5%	+$210K	0.15%	131
2016 Q3	$4.54M	Sell	37,358 -33,808	-48%	-$4.56M	0.14%	165
2016 Q2	$10.1M	Buy	71,166 +63,512	+830%	+$9.36M	0.33%	62
2016 Q1	$999K	Buy	+7,654	New	+$953K	0.03%	506
2015 Q4	–	Sell	-2,387	Closed	-$317K	–	910
2015 Q3	$317K	Sell	2,387 -18,710	-89%	-$3.22M	0.01%	543
2015 Q2	$3.71M	Sell	21,097 -30,595	-59%	-$5.49M	0.1%	226
2015 Q1	$8.93M	Buy	51,692 +21,470	+71%	+$3.68M	0.23%	96
2014 Q4	$5.04M	Buy	30,222 +16,648	+123%	+$2.76M	0.11%	201
2014 Q3	$2.18M	Sell	13,574 -8,953	-40%	-$1.38M	0.05%	354
2014 Q2	$3.31M	Sell	22,527 -42,036	-65%	-$5.83M	0.11%	272
2014 Q1	$8.95M	Buy	+64,563	New	+$9.72M	0.26%	117

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Oxford Asset Management's JAZZ Position: Q1 2020 in Review

Oxford Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2020, closing a stake of 9,259 shares — an estimated $1.38M sold.

Oxford Asset Management first reported a position in JAZZ in Q1 2014 and held it in 19 quarters. The position peaked at $10.1M in Q2 2016. 407 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

Oxford Asset Management reported no remaining Jazz Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 9,259 Jazz Pharmaceuticals shares in Q1 2020, an estimated $1.38M.
Oxford Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 19 quarters.
Oxford Asset Management's Jazz Pharmaceuticals position peaked at $10.1M in Q2 2016.
407 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.